Institut Curie Paris — Paris

Public research footprint of Institut Curie Paris, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Cancer · Triple Negative Breast Cancer · Unresectable Primary Central Chondrosarcoma · Relapsed Ovarian Cancer

Recently updated registry entries

NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT01874353 — Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial… (Active Not Recruiting)
NCT07491380 — Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut Curie Paris?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.